Boothbay Fund Management’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-27,520
Closed -$308K 2398
2021
Q2
$308K Sell
27,520
-483,175
-95% -$5.1M 0.01% 1262
2021
Q1
$5.15M Buy
510,695
+3,360
+0.7% +$38.2K 0.19% 96
2020
Q4
$5.18M Buy
507,335
+479,815
+1,744% +$5.02M 0.19% 93
2020
Q3
$287K Sell
27,520
-450,300
-94% -$4.69M 0.02% 819
2020
Q2
$4.76M Buy
+477,820
New +$4.8M 0.33% 61

Boothbay Fund Management's CHAQ.U Position: Q3 2021 in Review

Boothbay Fund Management sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q3 2021, closing a stake of 27,520 shares — an estimated $308K sold.

Boothbay Fund Management first reported a position in CHAQ.U in Q2 2020 and held it in 5 quarters. The position peaked at $5.18M in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.U as of Q3 2021.

  • Boothbay Fund Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 27,520 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q3 2021, an estimated $308K.
  • Boothbay Fund Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q2 2020 and held it in 5 quarters.
  • Boothbay Fund Management's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $5.18M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.